莎普爱思(603168)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603168 莎普爱思

已收盘 04-25 15:00:00

{"stockData":{"symbol":"603168","market":"SH","secType":"STK","nameCN":"莎普爱思","latestPrice":6.42,"timestamp":1745564400000,"preClose":6.49,"halted":0,"volume":4491160,"delay":0,"changeRate":-0.0108,"floatShares":323000000,"shares":376000000,"eps":-0.2256,"marketStatus":"已收盘","change":-0.07,"latestTime":"04-25 15:00:00","open":6.49,"high":6.53,"low":6.41,"amount":28958700,"amplitude":0.0185,"askPrice":6.43,"askSize":137,"bidPrice":6.42,"bidSize":978,"shortable":0,"etf":0,"ttmEps":-0.2256,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745803800000},"marketStatusCode":5,"adr":0,"adjPreClose":6.49,"symbolType":"stock","openAndCloseTimeList":[[1745544600000,1745551800000],[1745557200000,1745564400000]],"highLimit":7.14,"lowLimit":5.84,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":375925005,"isCdr":false,"pbRate":1.43,"roa":"--","roe":"--","epsLYR":0.07,"committee":0.451327,"marketValue":2413000000,"turnoverRate":0.0139,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-04-28。","floatMarketCap":2071000000},"requestUrl":"/m/hq/s/603168","defaultTab":"news","newsList":[{"id":"2529526771","title":"莎普爱思04月23日遭主力抛售140万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529526771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529526771?lang=zh_cn&edition=full","pubTime":"2025-04-23 15:20","pubTimestamp":1745392852,"startTime":"0","endTime":"0","summary":"04月23日, 莎普爱思股价跌1.07%，报收6.49元，成交金额2668万元，换手率1.27%，振幅2.29%，量比0.87。莎普爱思今日主力资金净流出140万元，连续3日净流出，上一交易日主力净流出284万元。该股近5个交易日上涨1.09%，主力资金累计净流出824万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出2355万元，其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423161552a4639b4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423161552a4639b4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2529809163","title":"美国关税或致药品短缺？行业警告：低利润仿制药面临停产危机","url":"https://stock-news.laohu8.com/highlight/detail?id=2529809163","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529809163?lang=zh_cn&edition=full","pubTime":"2025-04-21 18:06","pubTimestamp":1745230017,"startTime":"0","endTime":"0","summary":"特朗普口中的“关税武器”，瞄准了全球仰赖的仿制药供应链。据央视新闻，美国或对进口药品征收关税。特朗普多次放话，药品可能被纳入征税范围。本周，美国商务部也宣布对药品进口是否构成“国家安全风险”启动调查。要知道，仿制药承担了美国约90%的药品供应，本身利润就极其微薄，加征关税一旦成真，部分药企或直接停产。目前美国大部分仿制药产自印度和东南亚，美国很难自给自足。事实上，美国药品供应紧张早已有苗头。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421180725a6c227a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421180725a6c227a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688356","688321","603811","600079","603538","603707","603168","688506","688247","600267","600789","688513","688578","603351","688076","603676","600774","603207","603229","600521","688758","600624","605116","600276","688566","600613","688166","600664","600812","688799","BK0239","603669"],"gpt_icon":0},{"id":"2527468453","title":"莎普爱思04月15日遭主力抛售55万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527468453","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527468453?lang=zh_cn&edition=full","pubTime":"2025-04-15 15:20","pubTimestamp":1744701653,"startTime":"0","endTime":"0","summary":"04月15日, 莎普爱思股价跌0.30%，报收6.56元，成交金额2590万元，换手率1.22%，振幅1.82%，量比0.47。莎普爱思今日主力资金净流出55万元，连续7日净流出，上一交易日主力净流出110万元。|04月15日主力加仓幅度排名||#|股票简称|主力净额占比|#|N信凯科技|23.75%|#|三态股份|8.94%|#|新亚电缆|8.44%|#|...|...|#2732|莎普爱思|-0.03%|莎普爱思所在的化学制药行业，今日主力净流出4.52亿元，行业排名22/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415162353a6baf6e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415162353a6baf6e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2518795785","title":"莎普爱思最新公告：阿奇霉素滴眼液III期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2518795785","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518795785?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:23","pubTimestamp":1741681410,"startTime":"0","endTime":"0","summary":"莎普爱思公告称，公司组织开展的阿奇霉素滴眼液III期临床试验已完成首例受试者入组。该试验采用多中心、随机、双盲、安慰剂对照设计，旨在评价阿奇霉素滴眼液在中国化脓性细菌性结膜炎患者中的有效性和安全性。截至公告披露日，该项目累计研发投入约1449.72万元人民币。根据相关法律法规要求，药物需完成临床试验后方可进行药品注册上市许可申请。公司将根据药物研发的实际进展情况及时履行披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031100028168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03347","BK1583","BK1576","603168","BK0239","BK1141"],"gpt_icon":0},{"id":"2518606667","title":"莎普爱思(603168.SH)：阿奇霉素滴眼液III期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2518606667","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518606667?lang=zh_cn&edition=full","pubTime":"2025-03-11 15:48","pubTimestamp":1741679293,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莎普爱思(603168.SH)发布公告，近日，公司组织开展的阿奇霉素滴眼液III期临床试验完成首例受试者入组。阿奇霉素滴眼液III期临床试验，采用多中心、随机、双盲、安慰剂对照设计，评价阿奇霉素滴眼液在中国化脓性细菌性结膜炎患者中的有效性和安全性，已于2025年3月10日完成首例受试者入组。截至公告披露日，阿奇霉素滴眼液项目累计研发投入约1,449.72万元人民币。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1260297.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK4134","603168","BK1141","03347","BK1576","III","BK0239"],"gpt_icon":0},{"id":"2517180075","title":"莎普爱思03月06日主力净流入30万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2517180075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517180075?lang=zh_cn&edition=full","pubTime":"2025-03-06 15:19","pubTimestamp":1741245591,"startTime":"0","endTime":"0","summary":"03月06日, 莎普爱思股价涨2.08%，报收6.86元，成交金额4116万元，换手率1.88%，振幅2.83%，量比1.04。莎普爱思今日主力资金净流入30万元，上一交易日主力净流出8万元。该股近5个交易日下跌1.86%，主力资金累计净流出617万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出3314万元，其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306155752abeaf908&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306155752abeaf908&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2517602609","title":"莎普爱思03月05日主力净流出8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2517602609","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517602609?lang=zh_cn&edition=full","pubTime":"2025-03-05 15:21","pubTimestamp":1741159303,"startTime":"0","endTime":"0","summary":"03月05日, 莎普爱思股价跌2.89%，报收6.72元，成交金额5030万元，换手率2.32%，振幅4.34%，量比1.38。莎普爱思今日主力资金净流出8万元，上一交易日主力净流入135万元。该股近5个交易日下跌4.00%，主力资金累计净流出1124万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出3242万元，其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305162859a2604b84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305162859a2604b84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2516641386","title":"莎普爱思03月04日主力净流入135万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2516641386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516641386?lang=zh_cn&edition=full","pubTime":"2025-03-04 15:19","pubTimestamp":1741072792,"startTime":"0","endTime":"0","summary":"03月04日, 莎普爱思股价涨1.32%，报收6.92元，成交金额2519万元，换手率1.14%，振幅2.05%，量比0.67。莎普爱思今日主力资金净流入135万元，上一交易日主力净流出306万元。该股近5个交易日上涨0.87%，主力资金累计净流出1314万元；近20日主力资金累计净流出3097万元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304155919abe76acb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304155919abe76acb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2514826989","title":"莎普爱思02月27日遭主力抛售477万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514826989","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514826989?lang=zh_cn&edition=full","pubTime":"2025-02-27 15:19","pubTimestamp":1740640746,"startTime":"0","endTime":"0","summary":"02月27日, 莎普爱思股价跌0.14%，报收6.99元，成交金额3725万元，换手率1.66%，振幅2.43%，量比1.09。莎普爱思今日主力资金净流出477万元，连续4日净流出，上一交易日主力净流出199万元。|02月27日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|好想你|8.01%|#|瑞德智能|6.64%|#|天和磁材|6.25%|#|万控智造|5.10%|#|东方精工|4.81%|#|夏厦精密|4.68%|#|中科云网|4.63%|#|富岭股份|4.53%|#|茂硕电源|4.44%|#|中电兴发|4.33%|莎普爱思所在的化学制药行业，今日主力净流入1.38亿元，行业排名15/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227154446a255f423&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227154446a255f423&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2514833696","title":"莎普爱思收盘上涨2.04%，最新市净率1.56，总市值26.31亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514833696","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514833696?lang=zh_cn&edition=full","pubTime":"2025-02-26 19:08","pubTimestamp":1740568138,"startTime":"0","endTime":"0","summary":"2月26日，莎普爱思今日收盘7.0元，上涨2.04%，最新市净率1.56，总市值26.31亿元。股东方面，截至2024年9月30日，莎普爱思股东户数31175户，较上次减少291户，户均持股市值35.28万元，户均持股数量2.76万股。公司核心产品莎普爱思滴眼液属于眼科用药领域。公司利用营销网络优势,为莎普爱思滴眼液树立了良好的品牌和知名度,在国内白内障药物市场中处于行业前列。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/26190848408497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2514889971","title":"2月26日莎普爱思发布公告，股东减持166.19万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2514889971","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514889971?lang=zh_cn&edition=full","pubTime":"2025-02-26 17:06","pubTimestamp":1740560767,"startTime":"0","endTime":"0","summary":"证券之星消息，2月26日莎普爱思发布公告《莎普爱思:莎普爱思关于股东集中竞价减持股份结果公告》，其股东上海景兴实业投资有限公司于2024年11月27日至2025年2月26日间合计减持166.19万股，占公司目前总股本的0.4421%，变动期间该股股价下跌11.62%，截止2月26日收盘报7.0元。股东增减持详情见下表：根据莎普爱思2024年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022600029744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2514004984","title":"莎普爱思(603168.SH)：上海景兴合计减持166.19万股 减持期满","url":"https://stock-news.laohu8.com/highlight/detail?id=2514004984","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514004984?lang=zh_cn&edition=full","pubTime":"2025-02-26 15:32","pubTimestamp":1740555164,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莎普爱思(603168.SH)发布公告，上海景兴2024年11月22日减持股份计划的减持时间区间已届满，即自2024年11月27日至2025年2月26日期间，上海景兴通过集中竞价交易方式减持莎普爱思股份166.19万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254545.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2514517560","title":"莎普爱思：产品“盐酸奥洛他定滴眼液”取得注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2514517560","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514517560?lang=zh_cn&edition=full","pubTime":"2025-02-25 15:53","pubTimestamp":1740470001,"startTime":"0","endTime":"0","summary":"每经AI快讯，莎普爱思 2月25日晚间发布公告称，近日，浙江莎普爱思药业股份有限公司收到国家药品监督管理局核准签发的盐酸奥洛他定滴眼液《药品注册证书》。产品名称为“盐酸奥洛他定滴眼液”。2023年1至12月份，莎普爱思的营业收入构成为：医药工业占比72.74%，诊疗服务占比26.18%。莎普爱思的总经理、董事长均是林弘立，男，31岁，学历背景为本科。截至发稿，莎普爱思市值为26亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225155426962f8701&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225155426962f8701&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2514690059","title":"莎普爱思：获得盐酸奥洛他定滴眼液《药品注册证书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2514690059","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514690059?lang=zh_cn&edition=full","pubTime":"2025-02-25 15:39","pubTimestamp":1740469186,"startTime":"0","endTime":"0","summary":"每经AI快讯，2月25日，莎普爱思公告称，公司收到国家药品监督管理局核准签发的盐酸奥洛他定滴眼液《药品注册证书》。该药品用于治疗过敏性结膜炎相关的眼痒，注册分类为化学药品4类。截至公告披露日，公司针对该药品的累计研发投入约为434.56万元人民币。公司表示，药品未来的生产和销售受医药行业政策、招标采购、市场环境变化等诸多因素影响，对公司业绩的影响存在不确定性。文章来源：每日经济新闻原标题：莎普爱思：获得盐酸奥洛他定滴眼液《药品注册证书》","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225154912a2530d09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225154912a2530d09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2514568910","title":"莎普爱思：获得盐酸奥洛他定滴眼液《药品注册证书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2514568910","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514568910?lang=zh_cn&edition=full","pubTime":"2025-02-25 15:33","pubTimestamp":1740468833,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2514305681","title":"莎普爱思(603168.SH)：盐酸奥洛他定滴眼液获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2514305681","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514305681?lang=zh_cn&edition=full","pubTime":"2025-02-25 15:32","pubTimestamp":1740468723,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莎普爱思(603168.SH)发布公告，公司收到国家药品监督管理局核准签发的盐酸奥洛他定滴眼液《药品注册证书》。本次获批的盐酸奥洛他定滴眼液，用于治疗过敏性结膜炎相关的眼痒。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253945.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2513772744","title":"莎普爱思02月24日主力净流出302万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2513772744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513772744?lang=zh_cn&edition=full","pubTime":"2025-02-24 18:55","pubTimestamp":1740394501,"startTime":"0","endTime":"0","summary":"02月24日, 莎普爱思股价跌0.14%，报收6.93元，成交金额3292万元，换手率1.48%，振幅2.31%，量比0.77。莎普爱思今日主力资金净流出302万元，上一交易日主力净流入36万元。该股近5个交易日下跌2.53%，主力资金累计净流出1234万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出1078万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224192222abdad4c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224192222abdad4c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2512492057","title":"莎普爱思02月20日主力资金流出260万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2512492057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512492057?lang=zh_cn&edition=full","pubTime":"2025-02-20 15:19","pubTimestamp":1740035961,"startTime":"0","endTime":"0","summary":"02月20日, 莎普爱思股价涨1.45%，报收6.99元，成交金额4080万元，换手率1.81%，振幅3.05%，量比0.96。莎普爱思今日主力资金净流出260万元，连续3日净流出，上一交易日主力净流出244万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为50.00%，平均跌幅为2.06%。该股近5个交易日上涨1.75%，主力资金累计净流出468万元；近20日主力资金累计净流出1136万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220152840abd5cf3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220152840abd5cf3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2512212496","title":"AI+医疗行业深度：AI+医药：势不可挡，未来已至","url":"https://stock-news.laohu8.com/highlight/detail?id=2512212496","media":"中邮证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512212496?lang=zh_cn&edition=full","pubTime":"2025-02-19 15:04","pubTimestamp":1739948697,"startTime":"0","endTime":"0","summary":"投资要点“AI+医疗”解决方案全球市场有望突破千亿美元，有望进入到商业化加速阶段。“AI+医疗”行业人工智能解决方案的全球市场规模预计将由2022年的137亿美元增至2030年的1,553亿美元，CAGR为35.5%，行业存在爆发式增长机会。政策面上，国内宏观政策利好AI制药，医疗AI三类证审批加速。我们认为“AI+医疗”有望应用于药物研发、癌症诊断、医学影像、手术机器人等领域，行业或迎来巨变。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219150422a24b831f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219150422a24b831f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603520","603351","600216","688192","603676","688513","688091","688578","600079","603168","688235","688566","688505","BK0185","605116","600851","600613","600380","BK0239","688166","688176","688602","688189","688197","600488","600276","600664","600789","159891","600062","600196","BK0010","605507","603538","688062","688356","688382","688266","688221","688373","603367","605177","688553","688302","688321","688247","688690","688758","688799","BK0028","BK0188","601089","600812","600774","603669","159938","600624","600521","BK0175","603811","600200","688428","603207","688658","603229","600420","688076","600513","688117"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1745691426526,"stockEarnings":[{"period":"1week","weight":0.0016},{"period":"1month","weight":-0.0829},{"period":"3month","weight":-0.0213},{"period":"6month","weight":-0.2054},{"period":"1year","weight":-0.2453},{"period":"ytd","weight":-0.0418}],"compareEarnings":[{"period":"1week","weight":0.0056},{"period":"1month","weight":-0.0219},{"period":"3month","weight":0.013},{"period":"6month","weight":-0.0014},{"period":"1year","weight":0.0793},{"period":"ytd","weight":-0.0169}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江莎普爱思药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"31175人(较上一季度减少0.92%)","perCapita":"10347股","listingDate":"2014-07-02","address":"浙江省嘉兴市平湖市经济开发区新明路1588号","registeredCapital":"37592万元","survey":"　　浙江莎普爱思药业股份有限公司主营业务为医药制造板块以及医疗服务板块。主要产品为苄达赖氨酸滴眼液、大输液、头孢克肟、诊疗服务。公司核心产品莎普爱思滴眼液属于眼科用药(抗白内障类)领域。公司利用营销网络优势,为莎普爱思滴眼液树立了良好的品牌和知名度,在国内白内障药物市场中处于行业前列。根据北京东方比特科技有限公司《中国白内障滴眼液市场研究报告》数据显示,2019年公司莎普爱思滴眼液在我国白内障用药市场份额为21.51%。","listedPrice":21.85},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莎普爱思(603168)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莎普爱思(603168)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莎普爱思,603168,莎普爱思股票,莎普爱思股票老虎,莎普爱思股票老虎国际,莎普爱思行情,莎普爱思股票行情,莎普爱思股价,莎普爱思股市,莎普爱思股票价格,莎普爱思股票交易,莎普爱思股票购买,莎普爱思股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莎普爱思(603168)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莎普爱思(603168)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}